A paradigm shift in radiation treatment strategy for prostate cancer has been stimulated by precise radiotherapy including intensity-modulated radiotherapy (IMRT) and brachytherapy. Using IMRT technique, dose escalation has been achieved without increasing late gastrointestinal toxicities. Hypofractionation treatment protocols for prostate cancer with IMRT and image-guided radiotherapy may have a therapeutic advantage. Low dose rate brachytherapy may offer a better outcome for high-risk prostate cancer. However, in addition to the introduction of new technologies, it is also important to evaluate the quality of new treatment techniques in each institution.
|Number of pages
|Japanese Journal of Clinical Radiology
|Published - Sept 2013
All Science Journal Classification (ASJC) codes
- Radiology Nuclear Medicine and imaging